MMED
MiniMed GroupBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
Strong FY26 growth, rising CGM attachment, 659,000 pump users, and multiple product launches provide a credible path to FY27 growth acceleration. Flex, Go, Instinct, Vivera, and the Abbott collaboration are the main upside drivers.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -1.5.
What can break
FY27 growth and adjusted EBITDA margin guidance may not be achieved.
Momentum
86
Value
49
Sentiment
50
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $15.90 · Bull $19.00 · Bear $12.20
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $20.60
Why
Momentum86 · Δ7d -1.5
Value49 · Δ7d 0.0
Sentiment50 · Δ7d -26.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
86
26% active weight
Current posture
7d trendImproving
Δ7d
-1.5
Δ21d
-5.2
Value
49
39% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-
Sentiment
50
34% active weight
Current posture
7d trendSoftening
Δ7d
-26.3
Δ21d
-
Why this grade
Composite grade B. Momentum 86.0 / Value 48.9 / Sentiment 50.1
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$4.75B
Beta
-
Shares Out
280.84M
P/E (TTM) · Derived
-14.3
P/S (TTM)
-
P/FCF (TTM)
-
Rev YoY
+15.0%
EPS YoY
+1090.4%
Gross Margin
-
Op Margin
-
Net Debt
-
Current Ratio
1.59
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology